Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Research article

Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway

Authors: Li-Ying Song, Yu-Tao Ma, Wei-Jin Fang, Yang He, Jia-Li Wu, Shan-Ru Zuo, Zhen-Zhen Deng, Sheng-Feng Wang, Shi-Kun Liu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

Oxymatrine (OM), a quinolizidine alkaloid extracted from a herb Sophorae Flavescentis Radix, has been used to treat liver fibrotic diseases. However, the mechanism of its anti-fibrosis effects is still unclear. TGF-β/Smad signaling and miR-195 have been proved to paly an important role in hepatic stellate cells (HSCs) activation and liver fibrosis. In this study, we investigated whether OM could inhibit HSCs activation through TGF-β1/miR-195/Smads signaling or not.

Methods

First, the effects of OM on HSC-T6 in different concentrations and time points were tested by MTT assay. We choose three appropriate concentrations of OM as treatment concentrations in following experiment. By Quantitative Real-time PCR and Western Blot, then we investigated the effect of OM on miR-195, Smad7 and α-SMA’s expressions to prove the correlation between OM and the TGF-β1/miR-195/Smads signaling. Last, miR-195 mimic and INF-γ were used to investigate the relation between miR-195 and OM in HSC activation.

Results

Our results showed that the proliferation of HSC was significantly inhibited when OM concentration was higher than 200 μg/mL after 24 h, 100 μg/mL after 48 h and 10 μg/mL after 72 h. The IC50 of OM after 24, 48 and 72 h were 539, 454, 387 μg/mL respectively. OM could down-regulate miR-195 and α-SMA (P < 0.01), while up-regulate Smad7 (P < 0.05). In HSC-T6 cells transfected with miR-195 mimic and pretreated with OM, miR-195 and α-SMA were up-regulated (P < 0.05), and Smad7 was down-regulated (P < 0.05) .

Conclusions

Given these results, OM could inhibit TGF-β1 induced activation of HSC-T6 proliferation in a dose-dependent and time-dependent manner to some extent. We proved that OM inhibited HSC activation through down-regulating the expression of miR-195 and up-regulating Smad7.
Literature
1.
go back to reference Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair. [Journal Article]. 2012;5(1):1.CrossRef Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair. [Journal Article]. 2012;5(1):1.CrossRef
2.
go back to reference El BS, El KK, El-Ashmawy MB. Current progress in antifibrotics. Curr Med Chem. [Journal Article; Review]. 2011;18(20):3082–92. El BS, El KK, El-Ashmawy MB. Current progress in antifibrotics. Curr Med Chem. [Journal Article; Review]. 2011;18(20):3082–92.
3.
go back to reference Zhao Q, Qin CY, Zhao ZH, Fan YC, Wang K. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Tohoku J Exp Med. 2013;229(1):35–43 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef Zhao Q, Qin CY, Zhao ZH, Fan YC, Wang K. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Tohoku J Exp Med. 2013;229(1):35–43 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef
4.
go back to reference de Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, et al. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol. [Journal Article]. 2005;145(2):166–77.CrossRef de Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, et al. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol. [Journal Article]. 2005;145(2):166–77.CrossRef
5.
go back to reference Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181–94 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181–94 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef
6.
go back to reference Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. [Journal Article; Review]. 2017;14(7):397–411.CrossRef Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. [Journal Article; Review]. 2017;14(7):397–411.CrossRef
7.
go back to reference Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec (Hoboken). 2010;293(9):1492–6 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec (Hoboken). 2010;293(9):1492–6 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
8.
go back to reference Heymann F, Tacke F. Immunology in the liver--from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88–110 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef Heymann F, Tacke F. Immunology in the liver--from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88–110 [Journal Article; Research Support, Non-U.S. Gov't; Review].CrossRef
9.
go back to reference Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61(3):1066–79 [Journal Article; Research Support, N.I.H., Extramural; Review].CrossRef Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61(3):1066–79 [Journal Article; Research Support, N.I.H., Extramural; Review].CrossRef
10.
go back to reference Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–38 Journal Article; Review.CrossRef Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–38 Journal Article; Review.CrossRef
11.
go back to reference Murata M, Yoshida K, Yamaguchi T, Matsuzaki K. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma. World J Gastroenterol. 2014;20(41):15018–27 [Journal Article; Review].CrossRef Murata M, Yoshida K, Yamaguchi T, Matsuzaki K. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma. World J Gastroenterol. 2014;20(41):15018–27 [Journal Article; Review].CrossRef
12.
go back to reference Wang G, Matsuura I, He D, Liu F. Transforming growth factor-{beta}-inducible phosphorylation of Smad3. J Biol Chem. 2009;284(15):9663–73 [Journal Article; Research Support, N.I.H., Extramural].CrossRef Wang G, Matsuura I, He D, Liu F. Transforming growth factor-{beta}-inducible phosphorylation of Smad3. J Biol Chem. 2009;284(15):9663–73 [Journal Article; Research Support, N.I.H., Extramural].CrossRef
13.
go back to reference Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-beta/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol. 2014;45(4):1363–71 [Journal Article; Review].CrossRef Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-beta/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol. 2014;45(4):1363–71 [Journal Article; Review].CrossRef
14.
go back to reference Zhao HW, Zhang ZF, Chai X, Li GQ, Cui HR, Wang HB, et al. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-beta1 signaling pathways. Int Immunopharmacol. 2016;36:249–55 [Journal Article].CrossRef Zhao HW, Zhang ZF, Chai X, Li GQ, Cui HR, Wang HB, et al. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-beta1 signaling pathways. Int Immunopharmacol. 2016;36:249–55 [Journal Article].CrossRef
15.
go back to reference Dong XQ, Du Q, Yu WH, Zhang ZY, Zhu Q, Che ZH, et al. Anti-inflammatory Effects of Oxymatrine Through Inhibition of Nuclear Factor-kappa B and Mitogen-activated Protein Kinase Activation in Lipopolysaccharide-induced BV2 Microglia Cells. IRAN J Pharm Res. 2013;12(1):165–74 [Journal Article].PubMedPubMedCentral Dong XQ, Du Q, Yu WH, Zhang ZY, Zhu Q, Che ZH, et al. Anti-inflammatory Effects of Oxymatrine Through Inhibition of Nuclear Factor-kappa B and Mitogen-activated Protein Kinase Activation in Lipopolysaccharide-induced BV2 Microglia Cells. IRAN J Pharm Res. 2013;12(1):165–74 [Journal Article].PubMedPubMedCentral
16.
go back to reference Guzman JR, Koo JS, Goldsmith JR, Muhlbauer M, Narula A, Jobin C. Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629 [Journal Article; Research Support, N.I.H., Extramural].CrossRef Guzman JR, Koo JS, Goldsmith JR, Muhlbauer M, Narula A, Jobin C. Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629 [Journal Article; Research Support, N.I.H., Extramural].CrossRef
17.
go back to reference Ying XJ, Jin B, Chen XW, Xie J, Xu HM, Dong P. Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro. Biomed Res Int. 2015;2015:150390 Journal Article; Research Support, Non-U.S. Gov't.PubMedPubMedCentral Ying XJ, Jin B, Chen XW, Xie J, Xu HM, Dong P. Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro. Biomed Res Int. 2015;2015:150390 Journal Article; Research Support, Non-U.S. Gov't.PubMedPubMedCentral
18.
go back to reference Ma ZJ, Li Q, Wang JB, Zhao YL, Zhong YW, Bai YF, et al. Combining Oxymatrine or Matrine with Lamivudine Increased Its Antireplication Effect against the Hepatitis B Virus In Vitro. Evid Based Complement Alternat Med. 2013;2013:186573 [Journal Article].PubMedPubMedCentral Ma ZJ, Li Q, Wang JB, Zhao YL, Zhong YW, Bai YF, et al. Combining Oxymatrine or Matrine with Lamivudine Increased Its Antireplication Effect against the Hepatitis B Virus In Vitro. Evid Based Complement Alternat Med. 2013;2013:186573 [Journal Article].PubMedPubMedCentral
19.
go back to reference Jian YC, Li W, He Y, Jiang M, Liu YB, Xiong WJ. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats. Chin J Integr Med. 18(6):445–50 [Journal Article; Research Support, Non-U.S. Gov't]. 2012 2012-06-01.CrossRef Jian YC, Li W, He Y, Jiang M, Liu YB, Xiong WJ. Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats. Chin J Integr Med. 18(6):445–50 [Journal Article; Research Support, Non-U.S. Gov't]. 2012 2012-06-01.CrossRef
20.
go back to reference Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol. 2008;14(13):2100–5 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol. 2008;14(13):2100–5 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
21.
go back to reference Li L, Liu Q, Fan L, Xiao W, Zhao L, Wang Y, et al. Protective effects of oxymatrine against arsenic trioxide-induced liver injury. Oncotarget. 2017;8(8):12792–9 [Journal Article].PubMed Li L, Liu Q, Fan L, Xiao W, Zhao L, Wang Y, et al. Protective effects of oxymatrine against arsenic trioxide-induced liver injury. Oncotarget. 2017;8(8):12792–9 [Journal Article].PubMed
22.
go back to reference Katsuda T, Ochiya T. microRNAs act as a fine-tuner of liver development, regeneration, and carcinogenesis. Seikagaku. 2012;84(8):666–74 [Journal Article; Review].PubMed Katsuda T, Ochiya T. microRNAs act as a fine-tuner of liver development, regeneration, and carcinogenesis. Seikagaku. 2012;84(8):666–74 [Journal Article; Review].PubMed
23.
go back to reference Wang M, Zhang J, Tong L, Ma X, Qiu X. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. Int J Clin Exp Pathol. 2015;8(11):14110–20 Journal ArtSSS.PubMedPubMedCentral Wang M, Zhang J, Tong L, Ma X, Qiu X. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. Int J Clin Exp Pathol. 2015;8(11):14110–20 Journal ArtSSS.PubMedPubMedCentral
24.
go back to reference Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, et al. miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett. 2010;296(2):241–8 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K, et al. miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett. 2010;296(2):241–8 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
25.
go back to reference Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, et al. miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res. 2009;15(24):7684–92 [Journal Article].CrossRef Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, et al. miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res. 2009;15(24):7684–92 [Journal Article].CrossRef
26.
go back to reference Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol. 2011;226(10):2535–42 Journal Article; Research Support, Non-U.S. Gov't.CrossRef Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol. 2011;226(10):2535–42 Journal Article; Research Support, Non-U.S. Gov't.CrossRef
27.
go back to reference Duan Y, Chen Q. TGF-beta1 regulating miR-205/miR-195 expression affects the TGF-beta signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep. 2016;36(4):1837–44 [Journal Article].CrossRef Duan Y, Chen Q. TGF-beta1 regulating miR-205/miR-195 expression affects the TGF-beta signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep. 2016;36(4):1837–44 [Journal Article].CrossRef
28.
go back to reference Chen G, Cao S, Liu F, Liu Y. miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7. Biochem J. 2015;471(3):357–67 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Chen G, Cao S, Liu F, Liu Y. miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7. Biochem J. 2015;471(3):357–67 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
29.
go back to reference Song LY, Ma YT, Wu CF, Wang CJ, Fang WJ, Liu SK. MicroRNA-195 activates hepatic stellate cells in vitro by targeting Smad7. Biomed Res Int. 2017;2017:1945631 Journal Article. Song LY, Ma YT, Wu CF, Wang CJ, Fang WJ, Liu SK. MicroRNA-195 activates hepatic stellate cells in vitro by targeting Smad7. Biomed Res Int. 2017;2017:1945631 Journal Article.
30.
go back to reference Lee JI, Wright JH, Johnson MM, Bauer RL, Sorg K, Yuen S, et al. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis. Am J Physiol Cell Physiol. 2016;310(6):C436–45 [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't].CrossRef Lee JI, Wright JH, Johnson MM, Bauer RL, Sorg K, Yuen S, et al. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis. Am J Physiol Cell Physiol. 2016;310(6):C436–45 [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't].CrossRef
31.
go back to reference Bi WR, Yang CQ, Shi Q. Transforming growth factor-beta1 induced epithelial-mesenchymal transition in hepatic fibrosis. Hepatogastroenterology. 2012;59(118):1960–3 [Journal Article; Review].PubMed Bi WR, Yang CQ, Shi Q. Transforming growth factor-beta1 induced epithelial-mesenchymal transition in hepatic fibrosis. Hepatogastroenterology. 2012;59(118):1960–3 [Journal Article; Review].PubMed
32.
go back to reference He M, Wu Y, Wang M, Chen W, Yuan W, Jiang J. The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis. Evid Based Complement Alternat Med. 2015;2015:971616 [Journal Article; Review].PubMedPubMedCentral He M, Wu Y, Wang M, Chen W, Yuan W, Jiang J. The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis. Evid Based Complement Alternat Med. 2015;2015:971616 [Journal Article; Review].PubMedPubMedCentral
33.
go back to reference Zhang X, Jiang W, Zhou AL, Zhao M, Jiang DR. Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4/PI3K/Akt/GSK-3beta signaling pathway. World J Gastroenterol. 2017;23(21):3839–49 [Journal Article].CrossRef Zhang X, Jiang W, Zhou AL, Zhao M, Jiang DR. Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4/PI3K/Akt/GSK-3beta signaling pathway. World J Gastroenterol. 2017;23(21):3839–49 [Journal Article].CrossRef
34.
go back to reference Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, et al. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparalpha). Eur J Pharmacol. 2013;714(1–3):89–95 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, et al. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparalpha). Eur J Pharmacol. 2013;714(1–3):89–95 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
35.
go back to reference Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis, World J Gastroenterol. 2008;14(13):2100–5 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis, World J Gastroenterol. 2008;14(13):2100–5 [Journal Article; Research Support, Non-U.S. Gov't].CrossRef
Metadata
Title
Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway
Authors
Li-Ying Song
Yu-Tao Ma
Wei-Jin Fang
Yang He
Jia-Li Wu
Shan-Ru Zuo
Zhen-Zhen Deng
Sheng-Feng Wang
Shi-Kun Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2560-2

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue